NCT05887232

Brief Summary

Objective: To compare the effect of Fractional Carbon dioxide Laser (FCL) Vs Fractional Carbon dioxide Laser with platelet rich plasma (PRP) in management of Scars. Study design: Randomized-controlled trial (RCT). Study setting and duration: Dermatology Department, CMH-Abbottabad, November 2022/April 2023. Methodology: The sample size of 60 patients, age 18 to 50 years, was calculated by using Openepi app and the non-probability consecutive sampling technique was used. Patient in group A received FCL treatment's four sessions with four weeks apart, whereas Group B received four PRP and FCL sessions. The Quartile grading scale (score 0 is \<25%, score 1 is 25-50%, score 2 is 51-75% and score 3 is \>75% improvement) was used to assess the patient's clinical improvement at 4 weeks after each session. To determine statistical significance χ2-square test, taking p-value \<0.05 as significant, was used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 2, 2023

Completed
Last Updated

June 2, 2023

Status Verified

May 1, 2023

Enrollment Period

6 months

First QC Date

May 16, 2023

Last Update Submit

May 31, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quartile grading scale for assessment of scars

    Quartile grading scale was used to assess effectiveness of CO2 laser and CO2 laser with Platelet rich plasma in scars.Minimum score=0,Maximum Score=3 .Maximum score means better outcome.The Quartile grading scale (score 0 is \<25%, score 1 is 25-50%, score 2 is 51-75% and score 3 is \>75% improvement) was used to assess the patient's clinical improvement at 4 weeks after each session.

    16 weeks

Study Arms (2)

Fractional Co2 laser

ACTIVE COMPARATOR

Patient in group A received FCL treatment's four sessions four weeks apart.

Procedure: Fractional CO2 laser

Platelet Rich Plasma

ACTIVE COMPARATOR

Group B received fractional CO2 with four Platelet Rich Plasma sessions,4 weeks apart.

Procedure: Fractional CO2 with Platelet Rich Plasma

Interventions

Patient in group A received FCL treatments four sessions with four weeks apart

Fractional Co2 laser

Group B received four PRP and FCL sessions 4 weeks apart

Platelet Rich Plasma

Eligibility Criteria

Age18 Years - 50 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged 18-50 years
  • Fitzpatrick skin type III-V
  • Presented with post-acne, post traumatic or post burn scars
  • all those patients emotionally balanced with realistic expectations were included in the study.

You may not qualify if:

  • scar that was less than 6 months old
  • if they had an active infection or inflammatory skin condition
  • having a history of malignancy
  • a known connective tissue illness
  • history of excessive bleeding or keloids
  • unrealistic expectations
  • pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.Zahra Nigar

Abbottabad, KPK, 22010, Pakistan

Location

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

May 16, 2023

First Posted

June 2, 2023

Study Start

November 1, 2022

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

June 2, 2023

Record last verified: 2023-05

Locations